Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma	Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma	Recruiting	Phase 1 / Phase 2	2026-03-18		NCT07479732

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking University People's Hospital	269

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University People's Hospital	Beijing	China	68

Clinical trials